How to achieve synergy between volume replacement and filling products for global facial rejuvenation

Abstract

The objective of this paper is to provide an expert consensus regarding facial rejuvenation using a combination of volume replacement (Juvéderm^® VOLUMA^®), filling products (Juvéderm^® Ultra product line) and botulinum toxin. The Juvéderm product line exploits innovative 3-D technology, producing a range of cohesive, homogenous gels that produce predictable, long-lasting and natural results. The products are easy to use by practitioners and are well-tolerated by patients, and used in combination can provide additional benefits not achieved with one product alone. An assessment of facial anatomy and consideration of the aging process, as well as available treatment options, are also addressed in determining the best combination of products to use. Outcomes from a questionnaire and workshop sessions focusing on specific aspects of use of the Juvéderm product line and botulinum toxin in daily clinical practice are discussed, and recommendations for product use following debate amongst the experts are provided.

Key Words::

• botulinum toxin type-A (BoNTA)
• global facial rejuvenation
• hyaluronic acid (HA)
• Juvéderm^® Ultra
• Juvéderm^® VOLUMA^®

Acknowledgements

The authors would like to acknowledge Allergan Inc. for supporting the consensus meeting and for providing medical writing support for the production of this manuscript.

Conflict of interest: Allergan Inc. provided support for the organization of the expert meeting, including travel costs and expenses. Medical writing support for this paper was also provided by Allergan Inc.

Dr Raspaldo is a consultant for Allergan Inc.